Patients with chronic kidney disease had higher risk for ischemic and bleeding events at 2 years after PCI compared with patients with normal kidney function, researchers reported.
In addition, clinicians were more likely to discontinue dual antiplatelet therapy after 1 year in patients with chronic kidney disease (CKD), Usman Baber, MD, MS, assistant professor of medicine at Icahn School of Medicine at Mount Sinai and a Cardiology Today Next Gen Innovator, and colleagues found.
American College of Cardiology Annual Scientific Session
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.